QuidelOrtho Corp — Director's Dealing 2026

Feb 3, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QuidelOrtho Corp (QDEL)
CIK: 0001906324
Period of Report: 2026-01-30

Reporting Person: McLellan Philip D. (Chief Operations Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-31	Common Stock	A	1127	—	Acquired	17311	Direct
2026-01-31	Common Stock	F	421	$27.17	Disposed	16890	Direct
2026-01-31	Common Stock	A	847	—	Acquired	17737	Direct
2026-01-31	Common Stock	F	304	$27.17	Disposed	17433	Direct
2026-01-31	Common Stock	A	2009	—	Acquired	19442	Direct
2026-01-31	Common Stock	F	674	$27.17	Disposed	18768	Direct
2026-01-31	Common Stock	A	634	—	Acquired	19402	Direct
2026-01-31	Common Stock	F	228	$27.17	Disposed	19174	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-30	Restricted Stock Units	$	A	36152	Acquired		Common Stock (36152)	Direct
2026-01-30	Non-Qualified Stock Options	$27.17	A	36150	Acquired	2036-01-30	Common Stock (36150)	Direct
2026-01-31	Restricted Stock Units	$	M	1127	Disposed		Common Stock (1127)	Direct
2026-01-31	Restricted Stock Units	$	M	847	Disposed		Common Stock (847)	Direct
2026-01-31	Restricted Stock Units (Converted)	$	M	2009	Disposed		Common Stock (2009)	Direct
2026-01-31	Restricted Stock Units (Premium )	$	M	634	Disposed		Common Stock (634)	Direct

Footnotes

F1: Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4.

F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

F4: 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.

F5: 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.

F6: 2,254 shares vested in equal installments on January 31, 2025 and January 31, 2026.

F7: 846 shares vested on January 31, 2025 and 847 shares vested on January 31, 2026.

F8: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule.